Cargando…
P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430321/ http://dx.doi.org/10.1097/01.HS9.0000848208.53297.5e |
| _version_ | 1784779734462234624 |
|---|---|
| author | Duarte, D. Duarte, S. Sol dos Reis, C. Silva Coelho, P. Leite, L. Branca, R. Roncon, S. Pinho Vaz, C. Campos, A. |
| author_facet | Duarte, D. Duarte, S. Sol dos Reis, C. Silva Coelho, P. Leite, L. Branca, R. Roncon, S. Pinho Vaz, C. Campos, A. |
| author_sort | Duarte, D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430321 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94303212022-08-31 P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS Duarte, D. Duarte, S. Sol dos Reis, C. Silva Coelho, P. Leite, L. Branca, R. Roncon, S. Pinho Vaz, C. Campos, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430321/ http://dx.doi.org/10.1097/01.HS9.0000848208.53297.5e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Duarte, D. Duarte, S. Sol dos Reis, C. Silva Coelho, P. Leite, L. Branca, R. Roncon, S. Pinho Vaz, C. Campos, A. P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS |
| title | P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS |
| title_full | P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS |
| title_fullStr | P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS |
| title_full_unstemmed | P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS |
| title_short | P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS |
| title_sort | p1336: antiviral exposure to ganciclovir and valganciclovir is not associated with increased incidence of relapse or secondary malignancies in hematopoietic stem cell transplantation recipients |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430321/ http://dx.doi.org/10.1097/01.HS9.0000848208.53297.5e |
| work_keys_str_mv | AT duarted p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT duartes p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT soldosreisc p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT silvacoelhop p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT leitel p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT brancar p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT roncons p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT pinhovazc p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients AT camposa p1336antiviralexposuretoganciclovirandvalganciclovirisnotassociatedwithincreasedincidenceofrelapseorsecondarymalignanciesinhematopoieticstemcelltransplantationrecipients |